Vivek Ramaswamy

From Wikipedia, the free encyclopedia
Vivek Ramaswamy
Vivek Ramaswamy at The Future of Biomedical Research in Europe Basel Conference 2017.jpg
Ramaswamy in 2017
Born (1985-08-09) August 9, 1985 (age 36)
Cincinnati, Ohio, U.S.
Alma materSt. Xavier High School
Harvard University (AB)
Yale Law School (JD)
Title
  • Executive Chairman & Founder of Roivant Sciences
  • Co-founder of Chapter
  • Author of Woke, Inc.: Inside Corporate America's Social Justice Scam
Spouse(s)Apoorva Ramaswamy
Children1

Vivek Ramaswamy (born August 9, 1985) is an entrepreneur in the healthcare and technology sectors, a political commentator, and a New York Times bestselling author. He is the founder and executive chairman of the biopharmaceutical company Roivant Sciences. He is the author of Woke, Inc.: Inside Corporate America's Social Justice Scam, which was published in August 2021.[1]

Prior to founding Roivant in 2014, Ramaswamy co-founded a technology company and was a partner at an investment firm. He is writing and speaking against stakeholder capitalism, big tech censorship, and critical race theory more recently.[2]

Personal life and education[]

Ramaswamy was born and raised in Cincinnati, Ohio.[3][4]

He graduated from St. Xavier High School in Cincinnati in 2003.[5] In high school he was class valedictorian, a nationally ranked junior tennis player, and an accomplished pianist.

In 2007, Ramaswamy graduated from Harvard College summa cum laude and Phi Beta Kappa with an A.B. in biology. Ramaswamy wrote his senior thesis on the ethical questions raised by creating human-animal chimeras, under his mentor Professor Douglas Melton. His thesis was awarded the Bowdoin Prize for Natural Sciences, and a precis version of it was published by The New York Times and The Boston Globe in 2007.[6][7][8]

In 2013, Ramaswamy received a J.D. from Yale Law School, where his studies were supported by a postgraduate fellowship awarded to him by The Paul & Daisy Soros Fellowships for New Americans.[9]

Ramaswamy is married to Apoorva Tewari Ramaswamy, an Assistant Professor at the Ohio State University Wexner Medical Center.[10]

Career[]

In 2007, Ramaswamy co-founded and served as President of Campus Venture Network, a technology company that provided software and networking resources to university entrepreneurs.[11] The company was acquired in 2009 by the Ewing Marion Kauffman Foundation.

Ramaswamy worked at QVT Financial from 2007 to 2014, where he was a partner and co-managed the firm's biotech portfolio, while simultaneously attending Yale Law School from 2010-2013.[12] Ramaswamy appeared on the cover of Forbes magazine in 2015 for his work in drug development.[13]

Ramaswamy is the founder of the pharmaceutical company Roivant Sciences. Ramaswamy served as CEO of the company until 2021 when he became executive chairman. Roivant is focused on applying technology to drug development and has built several subsidiary biotech and healthcare technology companies, several of which are publicly listed.

Ramaswamy served on the board of directors of Myovant Sciences, a subsidiary of Roivant Sciences focused on the treatment of women's health diseases and other endocrine-related disorders. Myovant, formed in April 2016, raised $218 million in its initial public offering, the largest biotech IPO of 2016.[14]

Ramaswamy serves on the board of directors of Sumitovant Biopharma. Sumitovant is the result of a $3 billion transaction in 2019 which transferred ownership stakes in five companies in the Roivant family and includes investigational medicines which generated four successful Phase 3 studies in 2019.[15]

In 2020, Ramaswamy served on the Ohio COVID-19 Response Team.[16]

In early 2021, Ramaswamy stepped down as CEO of Roivant Sciences and became executive chairman to publish Woke, Inc.: Inside Corporate America's Social Justice Scam, which debuted at #2 on The New York Times bestseller list.[17]

Ramaswamy serves on the boards of directors of The Philanthropy Roundtable, FreOpp, and The Foundation for Research on Equal Opportunity.[18][19][20] In 2021, he became a member of the Board of Trustees of St. Xavier High School.[21]

Publications[]

  • The Chimera Question, New York Times, July 16, 2007[22]
  • This Pharma Company Stays Innovative by Doing Two Things, Harvard Business Review, March 14, 2017[23]
  • The ‘Stakeholders’ vs. the People, Wall Street Journal, February 12, 2020[24]
  • COVID-19 and American Identity, The Dispatch, July 14, 2020[25]
  • Antitrust Can't Bust a Monopoly of Ideas, Wall Street Journal, August 5, 2020[26]
  • End Corporate Privilege by Limiting Limited Liability, Newsweek, October 9, 2020[27]
  • The Pluralism Within, National Review, October 29, 2020[28]
  • Save the Constitution from Big Tech, Wall Street Journal, January 11, 2021[29]
  • ‘Stakeholder Capitalism’ Review: The Global, Olympian ‘We’, Wall Street Journal, January 25, 2021[30]
  • Save America's Workers from the Church of Wokeness, Newsweek, March 4, 2021[31]
  • Corporate America’s Siege on Democracy, National Review, April 13, 2021[32]
  • WOKE, INC.: Inside Corporate America's Social Justice Scam, Center Street, August 17, 2021 ISBN 9781546090786[33]
  • Which Woke Capitalism?, National Review, July 1, 2021[34]
  • Woke, Inc: Why I’m blowing whistle on how corporate America is poisoning society, New York Post, June 21, 2021[35]
  • Trump Can Win His Case Against Tech Giants, Wall Street Journal, July 11, 2021[36]

References[]

  1. ^ Berkowitz, Joe (2021-08-25). "This former tech CEO takes down woke capitalism but misses the point on wokeness". Fast Company. Retrieved 2021-10-14.
  2. ^ Creitz, Charles (2021-07-13). "Ramaswamy: 'Secular religion' of critical race theory now taught in schools violates Civil Rights Act of 64". Fox News. Retrieved 2021-07-16.
  3. ^ "A Look At the Race for Portmans Senate Seat". www.bizjournals.com. Retrieved 2021-10-28.
  4. ^ "CNS Summit - Speaker Details". cnssummit.org. Retrieved 2021-10-28.
  5. ^ Schulte, Becky (July 25, 2015). "July 2015". St. Xavier High School E-news (Mailing list). St. Xavier High School. Retrieved July 26, 2015.
  6. ^ "Opinion | The chimera question". The New York Times. 2007-07-16. ISSN 0362-4331. Retrieved 2021-10-22.
  7. ^ "Meet the Fellows | Vivek Ramaswamy". www.pdsoros.org. Retrieved 2021-10-22.
  8. ^ Yumpu.com. "Faculty of Arts and Sciences 2006-2007 Student Prize ... - iSites". yumpu.com. Retrieved 2021-10-22.
  9. ^ Vardi, Nathan. "The 30-Year-Old CEO Conjuring Drug Companies From Thin Air". Forbes.
  10. ^ "Apoorva Ramaswamy".
  11. ^ "Harvard Student Alum Launch Social Biz Site". www.bizjournals.com. Retrieved 2021-11-18.
  12. ^ Vardi, Nathan. "The 29 Year Old Behind The Giant Biotech IPO That Rose By 90% Speaks". Forbes.
  13. ^ "Forbes September 28, 2015 Vivek Ramaswamy Boy in the Bubble (Magazine: Finance, Business)". IndigoMistBooks. Retrieved 2020-05-13.
  14. ^ Vardi, Nathan. "Biggest Biotech IPO Of 2016 Is Launched By 31 Year Old". Forbes.
  15. ^ "Sumitomo Dainippon and Roivant Close Deal to Form Sumitovant Biopharma". BioSpace. Retrieved 2020-06-26.
  16. ^ "Swedish ambassador to the US on her country's path to 'herd immunity' against the coronavirus". Fox News. 2020-05-07. Retrieved 2020-05-13.
  17. ^ Reuters Staff (2021-01-25). "Roivant Sciences founder to step down as CEO". Reuters. Retrieved 2021-07-05.
  18. ^ "Our Leadership | The Philanthropy Roundtable". Philanthropy Roundtable. Retrieved 2021-11-18.
  19. ^ Service, Purdue News. "Speaker to consider implications of limiting free speech on social media". www.purdue.edu. Retrieved 2021-11-18.
  20. ^ FREOPP (2021-09-21). "FREOPP Leadership: Vivek Ramaswamy". Medium. Retrieved 2021-11-18.
  21. ^ "Board of Trustees - St. Xavier High School". www.stxavier.org. Retrieved 2021-11-18.
  22. ^ "The chimera question". Boston.com. Retrieved 2020-02-27.
  23. ^ "This Pharma Company Stays Innovative by Doing Two Things". Harvard Business Review. 2017-03-14. ISSN 0017-8012. Retrieved 2020-02-27.
  24. ^ "The 'Stakeholders' vs. the People". Wall Street Journal. 2020-02-13. ISSN 0099-9660. Retrieved 2020-02-27.
  25. ^ "COVID-19 and American Identity". thedispatch.com. Retrieved 2020-08-04.
  26. ^ "Opinion | Antitrust Can't Bust a Monopoly of Ideas". Wall Street Journal. 2020-08-05. ISSN 0099-9660. Retrieved 2020-08-14.
  27. ^ "End corporate privilege by limiting limited liability | Opinion". Newsweek. 2020-10-09. Retrieved 2020-10-14.
  28. ^ "The Pluralism Within". National Review. 2020-10-29. Retrieved 2020-11-10.
  29. ^ "Save the Constitution From Big Tech". Wall Street Journal. 2021-01-11. Retrieved 2021-01-21.
  30. ^ "'Stakeholder Capitalism' Review: The Global, Olympian 'We'". Wall Street Journal. 2021-01-25. Retrieved 2021-01-29.
  31. ^ "Save America's workers from the church of wokeness | Opinion". Newsweek. 2021-03-04. Retrieved 2021-09-23.
  32. ^ "Corporate America's Siege on Democracy". National Review. 2021-04-13. Retrieved 2021-09-23.
  33. ^ "WOKE, INC.: Inside Corporate America's Social Justice Scam". barnesandnoble.com. Center Street. Retrieved 30 April 2021.
  34. ^ "Which Woke Capitalism?". National Review. 2021-06-10. Retrieved 2021-11-24.
  35. ^ "Woke, Inc: Why I'm blowing whistle on how corporate America is poisoning society". New York Post. 2021-06-21. Retrieved 2021-11-24.
  36. ^ Ramaswamy, Vivek (2021-07-11). "Opinion | Trump Can Win His Case Against Tech Giants". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-11-24.
Retrieved from ""